Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia

Journal of the Neurological Sciences

Volumn 299, Issue 1-2, 2010, Pages 108-111

  Zekry, Dina ^a   Herrmann, François R ^a   Irminger Finger, Irmgard ^a   Graf, Cristophe ^a   Genet, Chantal ^a   Vitale, Anna Maria ^a   Michel, Jean Pierre ^a   Gold, Gabriel ^a   Krause, Karl Heinz ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aged; Alzheimer's disease; MCI; Mixed dementia; Telomere length; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PERIPHERAL LYMPHOCYTE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK FACTOR; TELOMERE; TELOMERE LENGTH;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; HUMANS; IN SITU HYBRIDIZATION; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; TELOMERE;

EID: 78649522897     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.07.019     Document Type: Article

References (34)

1. A. Papassotiropoulos, and C. Hock Biochemical markers of Alzheimer's disease: wish and reality Neurobiol Aging 23 2002 513 514
2. R.C. Allsopp, H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, and A.B. Futcher Telomere length predicts replicative capacity of human fibroblasts Proc Natl Acad Sci USA 89 1992 10114 10118
3. A. Aviv, and H. Aviv Reflections on telomeres, growth, aging, and essential hypertension Hypertension 29 1997 1067 1072
4. T. Davis, and D. Kipling Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing Biogerontology 6 2005 371 385
5. E. Jeanclos, A. Krolewski, J. Skurnick, M. Kimura, H. Aviv, and J.H. Warram Shortened telomere length in white blood cells of patients with IDDM Diabetes 47 1998 482 486
6. J. Lindsey, N.I. McGill, L.A. Lindsey, D.K. Green, and H.J. Cooke In vivo loss of telomeric repeats with age in humans Mutat Res 256 1991 45 48
7. K. Oexle, and A. Zwirner Advanced telomere shortening in respiratory chain disorders Hum Mol Genet 6 1997 905 908
8. T.S. Nawrot, J.A. Staessen, J.P. Gardner, and A. Aviv Telomere length and possible link to X chromosome Lancet 363 2004 507 510
9. H. Vaziri, and S. Benchimol From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging Exp Gerontol 31 1996 295 301
10. E.H. Blackburn Switching and signaling at the telomere Cell 106 2001 661 673
11. U. Friedrich, E. Griese, M. Schwab, P. Fritz, K. Thon, and U. Klotz Telomere length in different tissues of elderly patients Mech Ageing Dev 119 2000 89 99
12. C.B. Harley, H. Vaziri, C.M. Counter, and R.C. Allsopp The telomere hypothesis of cellular aging Exp Gerontol 27 1992 375 382
13. D. Zekry, F. Herrmann, R. Grandjean, A.-M. Vitale-Tiar, G. Gold, and K.-H. Krause Does cognitive impairment influence hospitalization outcomes? A prospective study in aged inpatients Int J Geriatr Psychiatry 24 2009 283 291
14. M.F. Folstein, S.E. Folstein, and P.R. Mac Hugh Mini Mental State: a practical method for grading the cognitive state of patients for the clinician J Pychiatr Res 12 1975 189 198
15. P.H. Robert, S. Schuck, B. Dubois, J.P. Olie, J.P. Lepine, and T. Gallarda Screening for Alzheimer's Disease with the short cognitive evaluation battery Dement Geriatr Cogn Disord 15 2003 92 98
16. P.R. Salomon, A. Hirschoff, B. Kelly, M. Relin, M. Brush, and R.D. DeVeaux A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease Arch Neurol 55 1998 349 355
17. H.W. van Marwijk, P. Wallace, G.H. de Bock, J. Hermans, A.A. Kaptein, and J.D. Mulder Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale Br J Gen Pract 45 1995 195 199
18. R. Gardner, S. Oliver-Munoz, L. Fisher, and L. Empting Mattis Dementia Rating Scale: internal reliability study using a diffusely impaired population J Clin Neuropsychol 3 1981 271 275
19. M. van der Linden Adaptation française de la procédure de Grober et Buschke 1999 Solal Marseille
20. R.M. Reitan Validity of the Trail-Making Test as an indicator of organic brain damage Percept Mot Skills 8 1958 271 276
21. K.A. Welsh, N. Butters, R.C. Mohs, D. Beekly, S. Edland, and G. Fillenbaum The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neurology 44 1994 609 614
22. J.C. Morris The clinical dementia rating: current version and scoring rules Neurology 43 1993 2412 2414
23. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th Ed Text Revision (DSM IV-TR) 2000 American Psychiatric Association Washington, DC
24. G. McKahn, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group Neurology 34 1984 939 944
25. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, and J.H. Garcia Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
26. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
27. M. Hultdin, E. Grönlund, K. Norrback, E. Eriksson-Lindström, T. Just, and G. Roos Telomere analysis by fluorescence in situ hybridization and flow cytometry Nucleic Acids Res 26 1998 3651 3656
28. T. von Zglinicki, V. Serra, M. Lorenz, G. Saretzki, R. Lenzen-Grossimlighaus, and R. Gessner Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 80 2000 1739 1747
29. L.A. Panossian, V.R. Porter, H.F. Valenzuela, X. Zhu, E. Reback, and D. Masterman Telomere shortening in T cells correlates with Alzheimer's disease status Neurobiol Aging 24 2003 77 84
30. C.M. Martin-Ruiz, J. Gussekloo, D. van Heemst, T. von Zglinicki, and R.G. Westendorp Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study Aging Cell 4 2005 287 290
31. C. Martin-Ruiz, H.O. Dickinson, B. Keys, E. Rowan, R.A. Kenny, and T. Von Zglinicki Telomere length predicts poststroke mortality, dementia, and cognitive decline Ann Neurol 60 2006 174 180
32. U. Friedrich, E. Griese, M. Schwab, P. Fritz, K. Thon, and U. Klotz Telomere length in different tissues of elderly patients Mech Ageing Dev 119 2000 89 99
33. K.D. Coon, A.J. Myers, D.W. Craig, J.A. Webster, J.V. Pearson, and D.H. Lince A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease J Clin Psychiatry 68 2007 613 618
34. Y. Davidson, L. Gibbons, N. Purandare, J. Byrne, J. Hardicre, and J. Wren Apolipoprotein E epsilon4 allele frequency in vascular dementia Dement Geriatr Cogn Disord 22 2006 15 19